RxDoctor Payments Data

Brittany Horton

Family · Chesapeake, VANPI 1619486982

Payments from drug & device makers

$2,263in general payments, 2019–2025

Across 146 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$644
  • Electronic Waveform Lab, Inc.$78
  • Abbott$57
  • GRT US Holding, Inc.$57
  • Nevro Corp.$50
  • plus $231 from 11 others

What the payments were for

  • Food & beverage$2,263100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,263 in reported general payments places this provider in the 80th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen20$77,591
NucyntaTapentadol Hcl42$42,598
Xtampza ErOxycodone Myristate50$28,335
OxycontinOxycodone Hcl37$22,008
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen609$17,252
Buprenorphine54$13,237
Lidocaine56$9,240
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen372$9,186
ButransBuprenorphine13$8,138
Oxycodone Hcl388$8,089
BelbucaBuprenorphine Hcl18$7,679
Tramadol Hcl ErTramadol Hcl85$5,642
Gabapentin319$5,190
Hydromorphone ErHydromorphone Hcl13$4,443
Morphine Sulfate ErMorphine Sulfate130$3,375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er, Belbuca$1,147$78,612110 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$16$14,51399 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,332 family providers in Virginia.

Other family in Chesapeake

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →